Clinical Lymphoma Myeloma and Leukemia

Real-world Survival, Healthcare Resource Utilization, and Costs among U.S. Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-GemOx in the Relapsed/Refractory Setting

Pub Date : 2024-02-01 DOI: 10.1016/j.clml.2024.01.010 M. Garg, J. Puckett, Sachin Kamal-Bahl, Monika Raut, K. Ryland, J. Doshi, Scott F Huntington

Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Pub Date : 2024-02-01 DOI: 10.1016/j.clml.2024.02.007 Samuel Yamshon, Caitlin Gribbin, Mohammad Alhomoud, Nora Chokr, Zhengming Chen, Michelle Demetres, M. Pasciolla, John Leonard, T. Shore, Peter Martin

Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study

Pub Date : 2024-02-01 DOI: 10.1016/j.clml.2024.02.006 H. Mian, Hsien Seow, Gregory Pond, Ana Gayowsky, R. Foley, Amaris Balistky, M. Ebraheem, Christopher Cipkar, Hyra Sapru, G. R. Mohyuddin, S. Hadidi, A. Visram